Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

This content is available also in other languages


This content is available also in other languages

February 2, 2007 | Corporate News | English

Heino von Prondzinsky steps down from the Board of Directors of Tecan

Zurich, Switzerland, 2 February 2007 – Heino von Prondzynski, who was elected onto Tecan’s Board of Directors in April 2006 by the General Shareholder’s Meeting on request of BB Medtech, informed the Board of Directors of Tecan on Friday afternoon of his immediate resignation. In his press release, accompanying his resignation, he made serious allegations against the Chairman of Tecan’s Board of Directors. The Chairman of Tecan dismissed these allegations as completely unfounded and wrong. The Board of Directors of Tecan thanks Heino von Prondzynski for his collaboration.


About Tecan

Tecan (www.tecan.com) is a leading player in the Life Sciences supply industry that specializes in the development, production, and distribution of solutions enabling the discovery of pharmaceutical substances, as well as for genomics, proteomics, and diagnostics. Tecan clients are leading pharmaceutical and biotechnology companies, university research departments and diagnostic laboratories. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. Registered shares of Tecan Group are traded on the SWX Swiss Exchange (TK: TECN / Reuters: TECZn.S / Valor : 1210019).

For further information please contact:

Sacha Wigdorovits
Contract Media AG
T +41 79 404 17 05